Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids [Phase 3]
Phase 3 clinical trial on masitinib for severe persistent asthma treated with oral corticosteroids has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: A Study to Evaluate the Effect of Gefapixant (AF-219/MK-7264) on Methacholine Hyper-reactivity in Participants With Asthma (MK-7264-009) [Phase 2]
Phase 2 trial evaluating Gefapixant (AF-219/MK-7264) for its effect on methacholine-induced hyperreactivity in participants with asthma; stu…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Systemic Corticosteroids Avoidance Study in Severe Asthma Patients [Phase 3]
Phase 3 trial studying avoidance of systemic corticosteroids in patients with severe asthma was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: RISA Extension Study - Long Term Safety
Long-term safety results from the RISA Extension Study in asthma have been completed, with results posted.
-
FDA approval · 2021-01-29FDA Approved: MONTELUKAST — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Montelukast from XLCare Pharmaceuticals Inc., approving changes to the generic product under…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-01-25FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Accord Healthcare Inc.'s montelukast sodium product under ANDA 202717.
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI Therapy [Phase 3]
Phase 3 trial update on efficacy and safety of Flutiform K-haler in uncontrolled asthma patients after mid-dose ICS/LABA therapy; study term…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited) [Phase 3]
Phase 3 study assessing albuterol sulfate inhalation aerosol (90 mcg) in asthma completed with results posted.
-
FDA approval · 2021-01-14FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application from Lupin Pharmaceuticals for albuterol sulfate, confirming approval of a generic inhalation produc…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: MGR001 / Advair Diskus Local Equivalence Study in Asthma [Phase 3]
Phase 3 trial update for MGR001/Advair Diskus local equivalence study in asthma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-01-07Clinical Trial Update: Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics [Phase 3]
Phase 3 study evaluating benralizumab on allergen-induced inflammation in mild, atopic asthma has completed with results posted.
-
FDA approval · 2021-01-06FDA Approved: QVAR REDIHALER — Supplemental Application (Teva Respiratory, LLC)
The FDA approved Teva Respiratory's supplemental application for QVAR REDIHALER (beclomethasone dipropionate HFA). The action pertains to a …
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma [Phase 3]
Phase 3 trial update on the efficacy of fevipiprant in nasal polyposis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients [Phase 1, Phase 2]
Clinical trial update reporting safety, tolerability, pharmacokinetics and pharmacodynamics of QAX576 in asthma patients across Phase 1 and …
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Characteristics of Pts Initiating Spiriva Respimat in Asthma
This clinical trial update describes the characteristics of asthma patients initiating Spiriva Respimat (tiotropium) in a completed study, w…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Dose Finding Study for QAW039 in Asthma [Phase 2]
Phase 2 dose-finding study for QAW039 in asthma has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Efficacy of QAX576 in Asthma [Phase 2]
Phase 2 trial results for QAX576 in asthma have been completed, reporting efficacy outcomes.
-
FDA approval · 2020-12-17FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma's generic inhalation powder combination of fluticasone propionate and salmeterol. It is indicated for the treatment of as…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma. [Phase 3]
Phase 3 clinical trial update on the safety and effectiveness of benralizumab for severe uncontrolled asthma has completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels [Phase 3]
Phase 3 clinical trial update for masitinib in severe uncontrolled asthma with elevated eosinophils has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects [Phase 2]
Phase 2 trial evaluating multiple dose levels of AZD7594 inhaled once daily in asthmatic subjects has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Pharmacokinetics of Inhaled Monodisperse Fluticasone Propionate [Phase 4]
Phase 4 study reporting pharmacokinetics of inhaled monodisperse fluticasone propionate in healthy individuals and asthma patients; results …
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Breath-Actuated Nebulizer Versus Conventional Continuous-Output Nebulizer in Pediatric Asthma Patients [NA]
Clinical trial comparing breath-actuated nebulizer to conventional continuous-output nebulizer in pediatric asthma; study terminated with re…
-
FDA approval · 2020-11-24FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for montelukast sodium. This action grants regulatory approval for c…
-
CLINICAL_TRIALS trial_result · 2020-11-23Clinical Trial Update: Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery [Phase 4]
A Phase 4 trial comparing daily mometasone furoate nasal spray alone versus combination with montelukast for chronic rhinosinusitis with ast…